Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them.
Company Details
- Employees
- 13
- Founded
- 2021
- Address
- Cambridge, Massachusetts 02138, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.kanotherapeutics.com
- HQ
- Cambridge, Massachusetts
Kano Therapeutics Questions
Kano Therapeutics's website is http://www.kanotherapeutics.com
Kano Therapeutics's LinkedIn profile is https://www.linkedin.com/company/kano-therapeutics
Kano Therapeutics has
13 employees.
View email and phone details for 13
employees at Kano Therapeutics.
Kano Therapeutics's industry is
Biotechnology Research
Kano Therapeutics's top competitors are
Cellino,
Cirrus Therapeutics,
Meiragtx,
In8bio,
Vsquared Ventures,
Halda Therapeutics,
Thymmune Therapeutics,
Bluerock Therapeutics,
4d Molecular Therapeutics,
Marker Therapeutics, Inc..
Kano Therapeutics's categories are Biotechnology Research
Kano Therapeutics's founding year is 2021
